Have a personal or library account? Click to login
The Role of Staphylococcus aureus in Secondary Infections in Patients with Atopic Dermatitis (AD) Cover

The Role of Staphylococcus aureus in Secondary Infections in Patients with Atopic Dermatitis (AD)

Open Access
|Aug 2016

References

  1. Abeck D. and M. Mempel. 1988. Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications. Br. J. Dermatol. 139 (Suppl 53): 13–16.10.1046/j.1365-2133.1998.1390s3013.x9990408
  2. Adamek-Guzik T., T.J. Guzik, M. Bzowska, G. Czerniawska- Mysik, D. Szmyd, J. Miedzobrodzki and J. Pryjma. 2001. Selected parameters of the cellular and humoral immunity in atopic dermatitis. Relationship to the severity of the disease (in Polish). Przegl. Lek. 58(12): 1029–1033.
  3. Bogdali M.A., G. Antoszczyk, W. Dyga, A. Obtulowicz, A. Bia- lecka, A. Kasprowicz, Z. Magnowska and K. Obtulowicz. 2016. Nickel allergy and relationship with Staphylococcus aureus in atopic dermatitis. J. Trace. Elem. Med. Biol. 33: 1–7.10.1016/j.jtemb.2016.02.00427049135
  4. Baran-Raunstrup K., J. Międzobrodzki and T. Ternowitz. 1998. Characteristics of Staphylococcus aureus isolates from atopic dermatitis with reference to proteolytic activity. Acta Microbiol. Pol. 47(2): 167–175.
  5. Boguniewicz M. and D.Y. Leung. 2011. Atopic dermatitis:a disease of altered skin barrier and immune dysregulation. Immunol. Rev. 242(1): 233–246.
  6. Bukowski M., B. Wladyka and G. Dubin. 2010. Exfoliative toxins of Staphylococcus aureus. Toxins (Basel) 2(5): 1148–1165.10.3390/toxins2051148315323722069631
  7. Bussmann C., S. Weidinger and N. Novak. 2011. Genetics of atopic dermatitis. J. Dtsch. Dermatol. Ges. 9(9): 670–676.
  8. Cavalcante F.S., E.D. Abad, Y.C. Lyra, S.B. , M. Ribeiro, D.C. Ferreira and K.R. dos Santos. 2015. High prevalence of methicillinresistance and PVL genes among Staphylococcus aureus isolates from the nares and skin lesions of pediatric patients with atopic dermatitis. Braz. J. Med. Biol. Res. 48(7): 588–594.
  9. Cheung G.Y., H.S. Joo, S.S. Chatterjee and M. Otto. 2014. Phenol- soluble modulins-critical determinants of staphylococcal virulence. FEMS Microbiol. Rev. 38(4): 698–719.
  10. Cogen A.L., K. Yamasaki, K.M. Sanchez, R.A. Dorschner, Y. Lai, D.T. MacLeod, J.W. Torpey, M. Otto, V. Nizet, J.E. Kim and R.L. Gallo. 2010. Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. J. Invest. Dermatol. 130(1): 192–200.10.1038/jid.2009.243279646819710683
  11. Cork M.J., S.G. Danby, Y. Vasilopoulos, J. Hadgraft, M.E. Lane, M. Moustafa, R.H. Guy, A.L. Macgowan, R. Tazi-Ahnini and S.J. Ward. 2009. Epidermal barrier dysfunction in atopic dermatitis. J. Invest. Dermatol. 129: 1892–1908.10.1038/jid.2009.13319494826
  12. Foelster Holst R., S. Reitamo, R. Yankova, M. Worm, M. Kadu- rina, D. Thaci, T. Bieber, N. Tsankov, A. Enk, T. Luger and others. 2010. The novel protease inhibitor SRD441 ointment is not effective in the treatment of adult subjects with atopic dermatitis: results of a randomized, vehicle-controlled study. Allergy 65(12): 1594–1599.10.1111/j.1398-9995.2010.02417.x21039597
  13. Gelmetti C. 2008. Local antibiotics in dermatology. Derm. Ther. 21: 18.10.1111/j.1529-8019.2008.00190.x18564249
  14. Gloor M., G. Peters and D. Stoika. 1982. On the resident aerobic bacterial skin flora in unaffected skin of patients with atopic dermatitis and in healthy controls. Dermatologica 164(4): 258–265.10.1159/0002500997044853
  15. Gong J.Q., L. Lin, T. Lin, F. Hao, F.Q. Zeng, Z.G. Bi, D. Yi and
  16. B. Zhao. 2006. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br. J. Dermatol. 155(4): 680–687.
  17. Gordon R.J. and F.D. Lowy. 2008. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin. Infect. Dis. 46(Suppl 5): S350–359.10.1086/533591247445918462090
  18. Grice E.A. and J.A. Segre. 2011. The skin microbiome. Nat. Rev. Microbiol. 9(4): 244–253. Erratum in: Nat. Rev. Microbiol. 9(8): 626.
  19. Guzik T.J., M. Bzowska, A. Kasprowicz, G. Czerniawska-Mysik, K. Wójcik, D. Szmyd, T. Adamek-Guzik and J. Pryjma. 2005. Persistent skin colonization with Staphylococcus aureus in atopic dermatitis: relationship to clinical and immunological parameters. Clin. Exp. Allergy 35(4): 448–455.
  20. Hanifin J.M. and Rajka G. 1980. Diagnostic features of atopic dermatitis. Acta Derm Venerol. 92: 44.
  21. Hauser C., B. Wuethrich, L. Matter, J.A. Wilhelm, W. Sonnabend and K. Schopfer. 1985. Staphylococcus aureus skin colonization in atopic dermatitis patients. Dermatologica 170: 35–39.10.1159/000249493
  22. Ide F., T. Matsubara, M. Kaneko, T. Ichiyama, T. Mukouyama and S. Furukawa. 2004. Staphylococcal enterotoxin-specific IgE antibodies in atopic dermatitis. Pediatr. Int. 46(3): 337–341.
  23. Jahreis A., P. Beckheinrich and U.F. Haustein. 2000. Effects of two novel cationic staphylococcal proteins (NP-tase and p70) and enterotoxin B on IgE synthesis and interleukin-4 and interferon-γ production in patients with atopic dermatitis. Br. J. Dermatol.142: 680–687.10.1046/j.1365-2133.2000.03412.x10792217
  24. Kloos W.E. and Schleifer K.H. 1986. Staphylococcus, pp. 431–434. In: Holt J.G. (ed). Bergey’s manual of systematic bacteriology. Williams & Wilkins, New York, USA.
  25. Kobayashi S.D. and F.R. DeLeo. 2009. An update on community associated MRSA virulence. Curr. Opin. Pharmacol. 9(5): 545–551.
  26. Krishna S. and L.S. Miller. 2012. Host-pathogen interactions between the skin and Staphylococcus aureus. Curr. Opin. Microbiol. 15(1): 28–35.
  27. Leung D.Y., M. Boguniewicz, M.D. Howell, I. Nomura and Q.A. Hamid. 2004. New insights into atopic dermatitis. J. Clin. Invest. 113(5): 651–657.
  28. Leyden J.J., R.R. Marples and A.M. Kligman. 1974. Staphylo coccus aureus in the lesions of atopic dermatitis. Br. J. Dermatol. 90(5): 525–530.
  29. Lis G., E. Cichocka-Jarosz, D. Gazurek, T. Szczerbiński, I. Głodzik, P. Sawiec and B. Białoruska. 2002. Relationships between atopy and bronchial hyper-reactivity in Polish school age children (in Polish). Przegl. Lek. 59(10): 780–784.
  30. Lomholt H., K.E. Andersen and M. Kilian. 2005. Staphylococcus aureus clonal dynamics and virulence factors in children with atopic dermatitis. J. Invest. Dermatol. 125(5): 977–982.
  31. Lübbe J. 2003. Secondary infections in patients with atopic dermatitis. Am. J. Clin. Dermatol. 4( 9): 641–654.10.2165/00128071-200304090-0000612926982
  32. Matsubara M., D. Harada, H. Manabe and K. Hasegawa. 2004. Staphylococcus aureus peptidoglycan stimulates granulocyte macrophage colony-stimulating factor production from human epidermal keratinocytes via mitogen-activated protein kinases. J. Invest. Dermatol. 566(1-3): 195–200.10.1016/j.febslet.2004.04.02815147894
  33. Międzobrodzki J., A.S. Naidu, J.L. Watts, P. Ciborowski, K. Palm and T. Wadstrom. 1989. Influence of milk on fibronectin and collagen type I binding to Staphylococcus aureus and coagulase-negative staphylococci isolated from Bovine mastitis. J. Clin. Microbiol. 27: 540–544.10.1128/jcm.27.3.540-544.19892673542775349
  34. Międzobrodzki J. and P. Kaszycki. 2000. Modyfication of Reactive- Oxygen intermediates (ROi) production by monocyte/macrophage treated with Staphylococcus aureus serine protease. Acta Microbiol. Pol. 49: 237–242
  35. Międzobrodzki J., P. Kaszycki, A. Białecka and A. Kasprowicz. 2002. Proteolytic activity of Staphylococcus aureus strains isolated from the colonized skin of patients with acute-phase atopic dermatitis. Eur. J. Clin. Microbiol. Infect. Dis. 21: 269–276.10.1007/s10096-002-0706-412072937
  36. Miedzobrodzki J., T. Panz, P.M. Płonka, K. Zajac, J. Dracz, K. Pytel, Ł. Mateuszuk and S. Chłopicki. 2008. Platelets augment respiratory burst in neutrophils activated by selected species of gram-positive or gram-negative bacteria. Folia Histochem. Cytobiol. 46(3): 383–388.
  37. Na S.Y., J.Y. Roh, J.M. Kim, M.D. Tamang and J.R. Lee. 2012. Analysis of colonization and genotyping of the exotoxins of Staphylococcus aureus in patients with atopic dermatitis. Ann. Dermatol. 24(4): 413–419.
  38. Naidu A.S., J. Miedzobrodzki and A. Forsgren. 1991. Human lactoferrin binding in clinical isolates of Staphylococcus aureus. J. Med. Microbiol. 34: 323–328.10.1099/00222615-34-6-3232056516
  39. Nakamura Y., J. Oscherwitz, K.B. Cease, S.M. Chan, R. Muñoz- Planillo, M. Hasegawa, A.E. Villaruz, G.Y. Cheung, M.J. McGavin, J.B. Travers and others. 2013. Staphylococcus δ-toxin induces allergic skin disease by activating mast cells. Nature 503(7476): 397–401.10.1038/nature12655409078024172897
  40. Nutten S. 2015. Atopic dermatitis: global epidemiology and risk factors. Ann. Nutr. Metab. 66(Suppl 1):8–16.10.1159/00037022025925336
  41. Orfali R.L., M.N. Sato, V.G. Santos, T.O. Titz, C.A. Brito, A.J. Duarte, R. Takaoka and V. Aoki. 2015. Staphylococcal enterotoxin B induces specific IgG4 and IgE antibody serum levels in atopic dermatitis. Int. J. Dermatol. 54(8): 898–904.
  42. Otto M. 2014. Staphylococcus aureus toxins. Curr. Opin. Microbiol. 17: 32–37.10.1016/j.mib.2013.11.004394266824581690
  43. Palmer C.N., A.D. Irvine, A. Terron-Kwiatkowski, Y. Zhao, H. Liao, S.P. Lee, D.R. Goudie, A. Sandilands, L.E. Campbell, F.J. Smith and others. 2006. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. 38: 441–446.10.1038/ng176716550169
  44. Petry V., G.R. Bessa, C.S. Poziomczyck, C.F. Oliveira, M.B. Weber, R.R. Bonamigo and P.A. d’Azevedo. 2012. Bacterial skin colonization and infections in patients with atopic dermatitis. An. Bras. Dermatol. 87(5): 729–734.
  45. Reginald K., K. Westritschnig, T. Werfel, A. Heratizadeh, N. Novak, M. Focke-Tejkl, A.M. Hirschl, D.Y. Leung, O. Elisyu- tina, E. Fedenko and others. 2011. Immunoglobulin E antibody reactivity to bacterial antigens in atopic dermatitis patients. Clin. Exp. Allergy 41(3): 357–369.
  46. Ring J., A. Alomar, T. Bieber, M. Deleuran, A. Fink-Wagner,
  47. C. Gelmetti, U. Gieler, J. Lipozencic, T. Luger, A.P. Oranje and others. 2012. Guidelines for treatment of atopic eczema (atopic dermatitis). Part I. J. Eur. Acad. Dermatol. Venereol. 26(8): 1045–1060.
  48. Ring J., D. Abeck and K. Neuber. 1992. Atopic eczema: role of microorganisms on the skin surface. Allergy 47(4 Pt 1): 265–269.10.1111/j.1398-9995.1992.tb02051.x1443443
  49. Rojo A., A. Aguinaga, S. Monecke, J.R. Yuste, G. Gastaminza and A. España. 2014. Staphylococcus aureus genomic pattern and atopic dermatitis: may factors other than superantigens be involved? Eur. J. Clin. Microbiol. Infect. Dis. 33(4): 651–658.
  50. Roll A., A. Cozzio, B. Fischer and P. Schmid-Grendelmeier. 2004. Microbial colonization and atopic dermatitis. Curr. Opin. Allergy Clin. Immunol. 4: 373–378.10.1097/00130832-200410000-0000815349036
  51. Sabat A.J., B. Wladyka., K. Kosowska-Shick, H. Grundmann, J.M. van Dijl, J. Kowal, P.C. Appelbaum, A. Dubin and W. Hrynie- wicz. 2008. Polymorphism, genetic exchange and intragenic recombination of the aureolysin gene among Staphylococcus aureus strains. BMC Microbiol. 29(8): 129.10.1186/1471-2180-8-129251584918664262
  52. Schlievert P.M., L.C. Case, K.L. Strandberg, B.B. Abrams and
  53. D.Y. Leung. 2008. Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis. Clin. Infect. Dis. 46(10): 1562–1567.
  54. Schlievert P.M., K.L. Strandberg, Y.C. Lin, M.L. Peterson and D.Y. Leung. 2010. Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J. Allergy Clin. Immunol. 125(1): 39–49.
  55. Soares J., C. Lopes, F. Tavaria, L. Delgado and M. Pintado. 2013. A diversity profile from the staphylococcal community on atopic dermatitis skin: a molecular approach. J. Appl. Microbiol. 115(6): 1411–1419.
  56. Sonesson A., J. Bartosik, J. Christiansen, I. Roscher, F. Nilsson, A. Schmidtchen and O. Bäck. 2013. Sensitization to skin-associated microorganisms in adult patients with atopic dermatitis is of importance for disease severity. Acta Derm. Venereol. 93(3): 340–345.10.2340/00015555-146523073977
  57. Sybilski A.J., F. Raciborski, A. Lipiec, A. Tomaszewska, A. Lusawa, P. Samel-Kowalik, A. Walkiewicz, E. Krzych, J. Komorowski and B. Samoliński. 2015. Atopic dermatitis is a serious health problem in Poland. Epidemiology studies based on the ECAP study (in Polish). Postepy Dermatol. Alergol. 32(1): 1–10.
  58. Ternowitz T. and T. Herlin. 1986. Defective monocyte and polymorphonuclear leukocyte chemotaxis and clinical characteristics in atopic dermatitis. Arch. Dermatol. Res. 278(6): 454–459.
  59. Werfel T. 2009. The role of leukocytes, keratinocytes, and allergenspecific IgE in the development of atopic dermatitis. J. Invest. Dermatol. 129: 1878–1891.
  60. Wilburg J., A. Kasprowicz and P.B. Heczko. 1984. Composition of normal bacterial flora of human skin in relation to the age and sex of examined persons (in Polish). Przegl. Dermatol. 71(6): 551–557.
DOI: https://doi.org/10.5604/17331331.1215600 | Journal eISSN: 2544-4646 | Journal ISSN: 1733-1331
Language: English
Page range: 253 - 259
Submitted on: Feb 26, 2016
Accepted on: Apr 11, 2016
Published on: Aug 26, 2016
Published by: Polish Society of Microbiologists
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2016 ANETA BUDA, JACEK MIĘDZOBRODZKI, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.